financetom
Business
financetom
/
Business
/
Colliers International Extends Global Chairman, Chief Executive Jay Hennick's Contract to 2029
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Colliers International Extends Global Chairman, Chief Executive Jay Hennick's Contract to 2029
Oct 2, 2024 10:07 PM

08:00 AM EDT, 10/01/2024 (MT Newswires) -- Colliers International Group ( CIGI ) said Tuesday it has extended the management services agreement with its Global Chairman and Chief Executive Jay Hennick to Jan. 1, 2029, from its previous expiration in April 2026.

Under this arrangement, the company said Hennick had been granted 428,174 cash-settled performance units, subject to certain performance-based vesting conditions through Jan. 1, 2029. Hennick is Colliers International Group's ( CIGI ) largest shareholder.

It added that if earned, Colliers would make a one-time cash payment based on the number of vested units multiplied by the twenty-day volume-weighted average trading price of its subordinate voting share.

For full vesting, Colliers' market capitalization must reach about $12.3 billion, double its value as of Dec. 31, 2023, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Altamira Medica, Pharma Nordic to Launch Bentrio Nasal Spray in Sweden, Denmark
Altamira Medica, Pharma Nordic to Launch Bentrio Nasal Spray in Sweden, Denmark
Aug 29, 2024
09:59 AM EDT, 08/23/2024 (MT Newswires) -- Altamira Therapeutics ( CYTO ) said Friday that its associate company, Altamira Medica, and its Norwegian partner Pharma Nordic have agreed to add Sweden and Denmark to the areas covered by their distribution agreement for the Bentrio nasal spray. Pharma Nordic plans to launch Bentrio in Sweden and Denmark next year following the...
Procter & Gamble Insider Sold Shares Worth $3,810,469, According to a Recent SEC Filing
Procter & Gamble Insider Sold Shares Worth $3,810,469, According to a Recent SEC Filing
Aug 29, 2024
10:03 AM EDT, 08/23/2024 (MT Newswires) -- Gary A Coombe, CEO, Grooming, on August 21, 2024, sold 22,377 shares in Procter & Gamble ( PG ) for $3,810,469. Following the Form 4 filing with the SEC, Coombe has control over a total of 38,719 shares of the company, with 36,961 shares held directly and 1,758 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/80424/000112760224022820/xslF345X05/form4.xml...
Champion Homes Insider Sold Shares Worth $262,610, According to a Recent SEC Filing
Champion Homes Insider Sold Shares Worth $262,610, According to a Recent SEC Filing
Aug 29, 2024
10:03 AM EDT, 08/23/2024 (MT Newswires) -- Joseph A. Kimmell, EVP, Operations, on August 21, 2024, sold 2,964 shares in Champion Homes ( SKY ) for $262,610. Following the Form 4 filing with the SEC, Kimmell has control over a total of 47,262 shares of the company, with 47,262 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/90896/000095017024100036/xslF345X05/ownership.xml Price: 89.03, Change: +0.69, Percent...
Evogene Prices $5.5 Million Registered Direct Offering
Evogene Prices $5.5 Million Registered Direct Offering
Aug 29, 2024
10:09 AM EDT, 08/23/2024 (MT Newswires) -- Evogene ( EVGN ) said Friday it has signed agreements with an unnamed institutional investor to sell about 1.7 million of its ordinary shares in a registered direct offering for gross proceeds of roughly $5.5 million. In a concurrent private placement, Evogene ( EVGN ) said it will issue unregistered series A ordinary...
Copyright 2023-2026 - www.financetom.com All Rights Reserved